[ORGANIZATION]
HOPE-3 trial
Featured in 1 tracked story · first seen
Situations
Deramiocel trial, FDA pivot, and ongoing lawsuit
5 clusters · 21 sources · last updated
Latest: Capricor Therapeutics pivots regulatory strategy amid legal challenges
Capricor Therapeutics is navigating a shifting regulatory and strategic landscape following an FDA advisory committee vote against the original effectiveness case for deramiocel in treating Duchenne cardiomyopathy. In re